Aytu BioPharma, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Aytu BioPharma, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q3 2025

May 14, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Q2 2025

Feb 12, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Q1 2025

Nov 13, 2024

Quarterly report10-Q

Earnings release8-K

2024

Q4 2024

Sep 26, 2024

Earnings release8-K

Annual report10-K

Q3 2024

May 15, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Feb 14, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

Nov 14, 2023

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Sep 27, 2023

Annual report10-K

Earnings release8-K

Q3 2023

May 11, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Feb 21, 2023

Quarterly report10-Q

Q1 2023

Nov 14, 2022

Quarterly report10-Q

2022

Q4 2022

Sep 27, 2022

Earnings release8-K

Annual report10-K

Q3 2022

May 15, 2022

Quarterly report10-Q

Q2 2022

Feb 14, 2022

Quarterly report10-Q

Q1 2022

Nov 15, 2021

Quarterly report10-Q

2021

Q4 2021

Sep 27, 2021

Earnings release8-K

Annual report10-K

2020

Q4 2020

Oct 6, 2020

Annual report10-K

2019

Q4 2019

Sep 26, 2019

Annual report10-K

2018

Q4 2018

Sep 6, 2018

Annual report10-K

2017

Q4 2017

Aug 31, 2017

Annual report10-K

2016

Q4 2016

Sep 1, 2016

Annual report10-K

2015

Q4 2015

Sep 28, 2015

Annual report10-K